Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

NDC labeler codes
55513
Strengths
Romosozumab 105 mg/1.17mL; Aflibercept 2 mg/.05mL; Adalimumab 40 mg/.4mL; Adalimumab 80 mg/.8mL; Adalimumab 40 mg/.8mL; Tezepelumab 210 mg/1.9mL; Erenumab 140 mg/mL; Erenumab 70 mg/mL; Epoetin 10000 [iU]/mL; Pegfilgrastim 4 mg/.4mL; Apremilast 75 mg/1; Eculizumab 300 mg/30mL; Sotorasib 240 mg/1; Apremilast 20 mg/1; Adalimumab 20 mg/.2mL; Adalimumab 10 mg/.2mL; Sotorasib 320 mg/1; Adalimumab 20 mg/.4mL; Sotorasib 120 mg/1; Rituximab 500 mg/50mL
Dosage forms
Injection, Solution, Solution, Injection, Kit, Tablet, Coated, Injection, Powder, Lyophilized, For solution, Tablet, Film coated, Injection, Suspension, Injection, Solution, Concentrate
Routes
Subcutaneous, Intravenous, Oral, Intravitreal, Intralesional
Drug classes (FDA established)
Erythropoiesis-stimulating Agent, Tumor Necrosis Factor Blocker, Leukocyte Growth Factor, Calcium-sensing Receptor Agonist, Vascular Endothelial Growth Factor Inhibitor, Phosphodiesterase 4 Inhibitor, Thrombopoietin Receptor Agonist, Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker, Thymic Stromal Lymphopoietin Blocker, CD20-directed Cytolytic Antibody, HER2/neu Receptor Antagonist, RANK Ligand Inhibitor, Epidermal Growth Factor Receptor Antagonist, Complement Inhibitor
Package NDCs
135

NDC codes

Newest listings first. Each row links to the product’s NDC page.

Amgen, Inc NDC Codes: finished products
ProductStrengthForm · routeProduct NDCPackage NDCs (11-digit)HCPCS
NeulastapegfilgrastimPegfilgrastim 4 mg/.4mLSolutionSubcutaneous55513-09955513-0099-01J2506
Evenityromosozumab-aqqgRomosozumab 105 mg/1.17mLInjection, SolutionSubcutaneous55513-50955513-0509-02—
Otezlaapremilast—Kit55513-51655513-0516-41—
OtezlaapremilastApremilast 75 mg/1Tablet, Film coatedOral55513-51955513-0519-30—
Bkemveculizumab-aeebEculizumab 300 mg/30mLInjection, Solution, ConcentrateIntravenous55513-18055513-0180-01—
Pavbluaflibercept-ayyhAflibercept 2 mg/.05mLInjection, SolutionIntravitreal55513-05655513-0056-0155513-0056-96J0178
Pavbluaflibercept-ayyhAflibercept 2 mg/.05mLInjection, SolutionIntravitreal55513-06555513-0065-0155513-0065-96J0178
Evenityromosozumab-aqqgRomosozumab 105 mg/1.17mLInjection, SolutionSubcutaneous55513-99855513-0998-02—
LumakrassotorasibSotorasib 240 mg/1Tablet, CoatedOral55513-51255513-0512-60—
Imdelltra (Amg757)tarlatamab-dlle—Kit55513-05955513-0059-01—
Imdelltra (Amg757)tarlatamab-dlle—Kit55513-07755513-0077-01—
OtezlaapremilastApremilast 20 mg/1Tablet, Film coatedOral55513-49755513-0497-60—
Otezlaapremilast—Kit55513-50855513-0508-55—
Otezlaapremilast—Kit55513-99655513-0996-95—
Amjevitaadalimumab-attoAdalimumab 20 mg/.2mLInjectionSubcutaneous55513-39955513-0399-01J0135
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneous55513-47955513-0479-0155513-0479-02J0135
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneous55513-48055513-0480-0155513-0480-02J0135
Amjevitaadalimumab-attoAdalimumab 80 mg/.8mLInjectionSubcutaneous55513-48155513-0481-0155513-0481-02J0135
Amjevitaadalimumab-attoAdalimumab 40 mg/.4mLInjectionSubcutaneous55513-48255513-0482-0155513-0482-02J0135
Amjevitaadalimumab-attoAdalimumab 10 mg/.2mLInjectionSubcutaneous55513-41355513-0413-01J0135
LumakrassotorasibSotorasib 320 mg/1Tablet, CoatedOral55513-50455513-0504-50—
Amjevitaadalimumab-attoAdalimumab 40 mg/.8mLInjectionSubcutaneous55513-40055513-0400-0155513-0400-0255513-0400-91J0135
Amjevitaadalimumab-attoAdalimumab 40 mg/.8mLInjectionSubcutaneous55513-41055513-0410-0155513-0410-02J0135
Amjevitaadalimumab-attoAdalimumab 20 mg/.4mLInjectionSubcutaneous55513-41155513-0411-01J0135
Tezspiretezepelumab-ekkoTezepelumab 210 mg/1.9mLInjection, SolutionSubcutaneous55513-11255513-0112-0155513-0112-96—
Tezspiretezepelumab-ekkoTezepelumab 210 mg/1.9mLInjection, SolutionSubcutaneous55513-12355513-0123-0155513-0123-96—
LumakrassotorasibSotorasib 120 mg/1Tablet, CoatedOral55513-48855513-0488-0255513-0488-2455513-0488-96—
Riabnirituximab-arrxRituximab 500 mg/50mLInjection, SolutionIntravenous55513-32655513-0326-0155513-0326-21J9312
Riabnirituximab-arrxRituximab 100 mg/10mLInjection, SolutionIntravenous55513-22455513-0224-0155513-0224-21J9312
Otezlaapremilast—Kit55513-36955513-0369-55—
Otezlaapremilast—Kit55513-48555513-0485-96—
OtezlaapremilastApremilast 30 mg/1Tablet, Film coatedOral55513-13755513-0137-6055513-0137-95—
Avsolainfliximab-axxqInfliximab 100 mg/10mLInjection, Powder, Lyophilized, For solutionIntravenous55513-67055513-0670-0155513-0670-21J1745
Kanjintitrastuzumab-annsTrastuzumab 150 mg/7.15mLInjection, Powder, Lyophilized, For solutionIntravenous55513-14155513-0141-0155513-0141-21J9355
NplateromiplostimRomiplostim 125 ug/.25mLInjection, Powder, Lyophilized, For solutionSubcutaneous55513-22355513-0223-0155513-0223-21—
Kanjintitrastuzumab-annsTrastuzumab 420 mg/20mLInjection, Powder, Lyophilized, For solutionIntravenous55513-13255513-0132-0155513-0132-21J9355
CorlanorivabradineIvabradine hydrochloride 5 mg/5mLSolutionOral55513-81355513-0813-28—
Evenityromosozumab-aqqgRomosozumab 105 mg/1.17mLInjection, SolutionSubcutaneous55513-88055513-0880-02—
Aimovigerenumab-aooeErenumab 140 mg/mLInjection, SolutionSubcutaneous55513-84255513-0842-01—
Aimovigerenumab-aooeErenumab 140 mg/mLInjection, SolutionSubcutaneous55513-84355513-0843-0055513-0843-01—
Mvasibevacizumab-awwbBevacizumab 100 mg/4mLInjection, SolutionIntravenous55513-20655513-0206-0155513-0206-21J9035
Mvasibevacizumab-awwbBevacizumab 400 mg/16mLInjection, SolutionIntravenous55513-20755513-0207-0155513-0207-21J9035
Aimovigerenumab-aooeErenumab 70 mg/mLInjectionSubcutaneous55513-84055513-0840-01—
Aimovigerenumab-aooeErenumab 70 mg/mLInjectionSubcutaneous55513-84155513-0841-0055513-0841-01—
ParsabivetelcalcetideEtelcalcetide hydrochloride 2.5 mg/.5mLInjection, SolutionIntravenous55513-74055513-0740-1055513-0740-20—
ParsabivetelcalcetideEtelcalcetide hydrochloride 5 mg/mLInjection, SolutionIntravenous55513-74155513-0741-1055513-0741-20—
ParsabivetelcalcetideEtelcalcetide hydrochloride 10 mg/2mLInjection, SolutionIntravenous55513-74255513-0742-1055513-0742-20—
Imlygictalimogene laherparepvecTalimogene laherparepvec 1000000 [PFU]/mLInjection, SuspensionIntralesional55513-07855513-0078-01—
Imlygictalimogene laherparepvecTalimogene laherparepvec 100000000 [PFU]/mLInjection, SuspensionIntralesional55513-07955513-0079-01—
CorlanorivabradineIvabradine hydrochloride 5 mg/1Tablet, Film coatedOral55513-80055513-0800-6055513-0800-99—

Amgen, Inc: common questions

What is Amgen, Inc's NDC labeler code?
55513. The labeler code is the first segment of each NDC. About labeler codes.
Is there a J-code for Amgen, Inc?
Med-Code's HCPCS directory matches J2506, J0178, J0135, J9312, J1745, J9355, J9035, J0897 to these products. NDC vs J-code.
Which NDC goes on a claim?
The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in